These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Femoral-popliteal Arteriosclerosis Obliterans:Review of Evidence-based Studies on Drug-eluting Endovascular Treatment]. Zhang R; Lai ZC; Liu CW Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):256-260. PubMed ID: 31060683 [TBL] [Abstract][Full Text] [Related]
7. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans. Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586 [TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology and diagnosis for arteriosclerosis obliterans]. Sasaki H; Konisi K Rinsho Byori; 2002 Aug; 50(8):802-6. PubMed ID: 12373817 [TBL] [Abstract][Full Text] [Related]
9. [The current status of arteriosclerosis obliterans in Japan]. Mishima Y Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):467-70. PubMed ID: 8808805 [TBL] [Abstract][Full Text] [Related]
10. [Endovascular therapy for peripheral arterial disease]. Urasawa K; Sato K; Koshida R; Honma Y Nihon Rinsho; 2011 Feb; 69(2):318-21. PubMed ID: 21387683 [TBL] [Abstract][Full Text] [Related]
11. [Arteriosclerosis obliterans that was improved by LDL apheresis]. Suzuki H; Mutoh E; Kitagawa T; Kubota H; Takasugi Y Hokkaido Igaku Zasshi; 1993 Jan; 68(1):126-31. PubMed ID: 8444401 [TBL] [Abstract][Full Text] [Related]
12. The clinical features and treatment of arteriosclerosis obliterans with diabetes. Tsushima N; Matsuo H; Hayashi T; Homma S Diabetes; 1996 Jul; 45 Suppl 3():S101-4. PubMed ID: 8674871 [TBL] [Abstract][Full Text] [Related]
13. Effects of selective LDL apheresis on plasma concentrations of ICAM-1, VCAM-1 and P-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis. Utsumi K; Kawabe M; Hirama A; Ueda K; Kamada Y; Arii K; Komaba Y; Katsura K; Iino Y; Katayama Y Clin Chim Acta; 2007 Feb; 377(1-2):198-200. PubMed ID: 17126824 [TBL] [Abstract][Full Text] [Related]
14. [Standardize the endovascular treatment for arteriosclerosis obliterans]. Wang SM; Yao C Zhonghua Wai Ke Za Zhi; 2016 Aug; 54(8):564-7. PubMed ID: 27502128 [TBL] [Abstract][Full Text] [Related]
16. [Surgical treatment of arteriosclerotic arterial occlusive disease]. Tada Y Nihon Rinsho; 1993 Aug; 51(8):2117-22. PubMed ID: 8411680 [TBL] [Abstract][Full Text] [Related]
17. Dilation and reduced distensibility of carotid artery in patients with abdominal aortic aneurysms. Makita S; Ohira A; Tachieda R; Itoh S; Moriai Y; Niinuma H; Nakamura M; Hiramori K Am Heart J; 2000 Aug; 140(2):297-302. PubMed ID: 10925346 [TBL] [Abstract][Full Text] [Related]
18. [The effects of different hydration strategies before endovascular treatments to the renal function of the arteriosclerosis obliterans patients]. Zhu YT; Xiong J; Guo W; Liu XP; Yin T; Jia X; Ma XH; DU X Zhonghua Yi Xue Za Zhi; 2010 May; 90(17):1155-8. PubMed ID: 20646558 [TBL] [Abstract][Full Text] [Related]
19. [Thermography in the diagnosis of atherosclerosis obliterans of the vessels of the lower extremities]. Zenovko GI Khirurgiia (Mosk); 1982 Feb; (2):96-8. PubMed ID: 7062680 [No Abstract] [Full Text] [Related]
20. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Li T; Cao H; Zhuang J; Wan J; Guan M; Yu B; Li X; Zhang W Clin Chim Acta; 2011 Jan; 412(1-2):66-70. PubMed ID: 20888330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]